Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$798M |
| 2 |
Netflix
NFLX
|
+$608M |
| 3 |
UnitedHealth
UNH
|
+$517M |
| 4 |
Apple
AAPL
|
+$461M |
| 5 |
GE Vernova
GEV
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$527M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 3 |
Meta Platforms (Facebook)
META
|
+$362M |
| 4 |
Advanced Micro Devices
AMD
|
+$328M |
| 5 |
Palantir
PLTR
|
+$327M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 12.38% |
| 4 | Financials | 11.53% |
| 5 | Industrials | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
Aura Biosciences
AURA
$728M
| $823K | ﹤0.01% |
131,548
+28,248
| +27% | +$165K |
|
2602
First Trust Utilities AlphaDEX Fund
FXU
$831M
| $822K | ﹤0.01% |
+19,400
| New | +$806K |
|
2603
Lumentum
LITE
$60.7B
| $808K | ﹤0.01% |
8,500
-30,800
| -78% | -$2.19M |
|
2604
ReNew
RNW
$2.29B
| $807K | ﹤0.01% |
116,800
+82,200
| +238% | +$537K |
|
2605
Crown Crafts
CRWS
$31.7M
| $805K | ﹤0.01% |
280,330
-11,533
| -4% | -$35.7K |
|
2606
Universal Corp
UVV
$1.3B
| $804K | ﹤0.01% |
13,811
-18,500
| -57% | -$1.07M |
|
|
FVR
2607
FrontView REIT
FVR
$473M
| $804K | ﹤0.01% |
+67,000
| New | +$792K |
|
2608
ACNB Corp
ACNB
$656M
| $804K | ﹤0.01% |
18,756
+1,400
| +8% | +$58.3K |
|
2609
iShares S&P 500 Value ETF
IVE
$49.3B
| $801K | ﹤0.01% |
+4,100
| New | +$764K |
|
2610
Lesaka Technologies
LSAK
$401M
| $798K | ﹤0.01% |
177,800
-7,476
| -4% | -$32.4K |
|
2611
FT Vest Fund of Buffer ETFs
BUFR
$10.2B
| $798K | ﹤0.01% |
25,100
-3,100
| -11% | -$93.3K |
|
2612
Vanguard S&P Mid-Cap 400 ETF
IVOO
$3.75B
| $798K | ﹤0.01% |
7,600
-2,600
| -25% | -$258K |
|
2613
Caesarstone
CSTE
$75.4M
| $797K | ﹤0.01% |
404,662
+44,560
| +12% | +$101K |
|
|
UBFO
2614
DELISTED
United Security Bancshares
UBFO
| $796K | ﹤0.01% |
92,048
+7,000
| +8% | +$59.8K |
|
2615
Pennant Group
PNTG
$1.4B
| $791K | ﹤0.01% |
26,500
-31,400
| -54% | -$862K |
|
2616
Citizens
CIA
$236M
| $789K | ﹤0.01% |
225,994
+17,100
| +8% | +$66.8K |
|
|
DOYU
2617
DouYu International Holdings
DOYU
$142M
| $787K | ﹤0.01% |
121,438
-600
| -0.5% | -$4.06K |
|
2618
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.37B
| $785K | ﹤0.01% |
+5,900
| New | +$739K |
|
|
GRDN
2619
Guardian Pharmacy Services
GRDN
$2.58B
| $782K | ﹤0.01% |
36,700
-67,365
| -65% | -$1.52M |
|
2620
Priority Technology Holdings
PRTH
$549M
| $780K | ﹤0.01% |
100,300
-79,300
| -44% | -$595K |
|
2621
State Street DoubleLine Total Return Tactical ETF
TOTL
$4.01B
| $780K | ﹤0.01% |
19,445
+745
| +4% | +$29.6K |
|
2622
Finance of America Companies
FOA
$209M
| $779K | ﹤0.01% |
33,387
-24,608
| -42% | -$518K |
|
2623
iShares Latin America 40 ETF
ILF
$3.82B
| $778K | ﹤0.01% |
+29,700
| New | +$738K |
|
2624
Digital Turbine
APPS
$1.09B
| $778K | ﹤0.01% |
+131,800
| New | +$542K |
|
2625
Pure Cycle
PCYO
$258M
| $777K | ﹤0.01% |
72,500
+35,700
| +97% | +$370K |
|
Similar funds
Renaissance Technologies's Q2 2025 Portfolio in Review
As of Q2 2025, Renaissance Technologies held 4,018 positions worth $75.2B, up 14% from $66.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q2 2025 filing shows 612 new, 1,577 increased, 1,314 reduced and 496 closed positions. Its largest new stake was UnitedHealth: 1,352,129 shares worth $422M. The largest sale was Broadcom, an estimated $527M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2025 buy was UnitedHealth: 1,352,129 shares worth $422M.
- Renaissance Technologies added most to NVIDIA in Q2 2025, an estimated $798M increase.
- Renaissance Technologies's biggest Q2 2025 reduction was Broadcom, cutting an estimated $527M.
- Renaissance Technologies fully exited Advanced Micro Devices in Q2 2025, selling an estimated $328M.
- Renaissance Technologies's ten largest holdings make up 12% of its $75.2B portfolio in Q2 2025.
- Renaissance Technologies opened 612 new positions and closed 496 in Q2 2025.
- Renaissance Technologies's portfolio value rose 14% quarter-over-quarter to $75.2B.
Based on Renaissance Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.